stars 1 stars 2 stars 3

Adanate is a biotechnology company developing antibodies against key receptors on the surface of both innate and adaptive immune cells. Dual modulation of the body’s immunity could provide a novel treatment strategy that allows for better control of cancer.

Adanate Questions

The Adanate annual revenue was $1 million in 2026.

Alice Gois is the CEO of Adanate.

1 people are employed at Adanate.

Adanate is based in La Jolla, California.

The NAICS codes for Adanate are [5417, 541714, 54, 54171, 541].

The SIC codes for Adanate are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users